| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | SELECT SECTOR SPDR TR | 440,000 | 31,900,000 | 5.38% | Put | |
| 2 | ALEXION PHARMACEUTIC | 114,978 | 19,926,000 | 3.36% | ||
| 3 | CELGENE CORP | 151,000 | 17,407,000 | 2.94% | ||
| 4 | MERCK & CO INC | 300,000 | 17,244,000 | 2.91% | ||
| 5 | BIOGEN INC | 40,700 | 17,185,000 | 2.90% | ||
| 6 | AMGEN INC | 99,000 | 15,825,000 | 2.67% | ||
| 7 | ALKERMES PLC SHS | 258,000 | 15,730,000 | 2.65% | ||
| 8 | GILEAD SCIENCES INC | 159,000 | 15,603,000 | 2.63% | ||
| 9 | UNITEDHEALTH GROUP INC | 130,000 | 15,378,000 | 2.59% | ||
| 10 | CVS HEALTH CORP | 145,000 | 14,965,000 | 2.52% | ||
| 11 | ALLERGAN PLC | 45,300 | 13,482,000 | 2.27% | ||
| 12 | ABBVIE INC | 220,000 | 12,879,000 | 2.17% | ||
| 13 | CARDINAL HEALTH INC | 141,400 | 12,764,000 | 2.15% | ||
| 14 | Esperion Therapeutics Inc | 126,926 | 11,753,000 | 1.98% | ||
| 15 | RITE AID CORP | 1,276,462 | 11,092,000 | 1.87% | ||
| 16 | INCYTE | 120,000 | 10,999,000 | 1.85% | ||
| 17 | NEKTAR THERAPEUTICS COM | 996,600 | 10,963,000 | 1.85% | ||
| 18 | UNIVERSAL HLTH SVCS INC | 87,000 | 10,241,000 | 1.73% | ||
| 19 | REGENERON PHARMACEUTICALS | 22,000 | 9,933,000 | 1.67% | ||
| 20 | JAZZ PHARMACEUTICALS PLC SHS USD | 55,000 | 9,503,000 | 1.60% | ||
| 21 | LILLY ELI & CO | 129,000 | 9,372,000 | 1.58% | ||
| 22 | BIOMARIN | 75,000 | 9,347,000 | 1.58% | ||
| 23 | MEDIVATION INC | 69,000 | 8,906,000 | 1.50% | ||
| 24 | Anthem Inc. | 57,000 | 8,801,000 | 1.48% | ||
| 25 | MCKESSON CORP | 38,000 | 8,596,000 | 1.45% | ||
| 26 | BRISTOL MYERS SQUIBB CO | 129,000 | 8,321,000 | 1.40% | ||
| 27 | Receptos Inc | 43,500 | 7,173,000 | 1.21% | ||
| 28 | VALEANT PHARMACEUTICALS INTL | 36,000 | 7,150,000 | 1.21% | ||
| 29 | LIVANOVA PLC | 108,000 | 7,011,000 | 1.18% | ||
| 30 | VERTEX PHARMACEUT | 58,000 | 6,842,000 | 1.15% | ||
| 31 | Becton Dickinson & C | 46,982 | 6,746,000 | 1.14% | ||
| 32 | Orexigen Therapeutics, Inc. | 831,800 | 6,513,000 | 1.10% | ||
| 33 | IONIS PHARMACEUTICAL | 102,000 | 6,494,000 | 1.09% | ||
| 34 | INTERCEPT PHARMACEUTICAL | 23,000 | 6,486,000 | 1.09% | ||
| 35 | CEMPRA INC | 185,300 | 6,358,000 | 1.07% | ||
| 36 | COMMUNITY HEALTH SYS INC NEW COM | 118,000 | 6,169,000 | 1.04% | ||
| 37 | ACADIA PHARMACEUTICALS INC COM | 171,000 | 5,573,000 | 0.94% | ||
| 38 | HCA HOLDINGS INC | 74,000 | 5,567,000 | 0.94% | ||
| 39 | ALNYLAM PHARMACEUTICALS INC | 53,000 | 5,534,000 | 0.93% | ||
| 40 | SUPERNUS PHARMACEUTICALS INC COM | 450,800 | 5,450,000 | 0.92% | ||
| 41 | MEDTRONIC INC | 69,000 | 5,381,000 | 0.91% | ||
| 42 | LABORATORY CORP AMER HLDGS | 39,000 | 4,918,000 | 0.83% | ||
| 43 | REVANCE THERAPEUTICS INC COM | 236,000 | 4,892,000 | 0.82% | ||
| 44 | CERNER CORP | 66,000 | 4,835,000 | 0.82% | ||
| 45 | DEXCOM | 77,000 | 4,800,000 | 0.81% | ||
| 46 | AMSURG CORP | 76,000 | 4,676,000 | 0.79% | ||
| 47 | TETRAPHASE PHARMACEUTICALS I COM | 122,000 | 4,470,000 | 0.75% | ||
| 48 | INTRA CELLULAR THERAPIES INC COM | 183,000 | 4,370,000 | 0.74% | ||
| 49 | AETNA INC NEW | 41,000 | 4,368,000 | 0.74% | ||
| 50 | CENCORA | 38,000 | 4,319,000 | 0.73% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001415889-15-001643, filed 2015.05.13).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
